Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy

Proton pump inhibitors (PPIs), H(+)/K(+)-ATPase inhibitors, are the most commonly prescribed drugs for the treatment of gastroesophageal reflux and peptic ulcer diseases; they are highly safe and tolerable. Since PPIs are frequently used in cancer patients, studies investigating interactions between...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikemura, Kenji, Hiramatsu, Shunichi, Okuda, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732944/
https://www.ncbi.nlm.nih.gov/pubmed/29311921
http://dx.doi.org/10.3389/fphar.2017.00911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732944/
https://www.ncbi.nlm.nih.gov/pubmed/29311921
http://dx.doi.org/10.3389/fphar.2017.00911

Ejemplares similares